Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers

American Journal of Gastroenterology

Volumn 92, Issue 1, 1997, Pages 119-123

  Niitsuma, Hirofumi ^a   Ishii, Motoyasu ^a   Miura, Masahito ^a   Kobayashi, Koju ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; INTERFERON; NUCLEOTIDE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIREMIA; VIRUS CARRIER;

ADULT; ANTIVIRAL AGENTS; CARRIER STATE; CHRONIC DISEASE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERONS; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIREMIA;

EID: 0031012970     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Karayiannis P, Fowler MJF, Lok ASF, et al. Detection of serum HBV-DNA by molecular hybridization. J Hepatol 1985;1:99-106.
2. Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64: 1298-303.
3. Lai MY, Chen DS, Lee SC, et al. Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: Molecular and immunohistochemical studies. Hepato-gastroenterology 1988;35:17-21.
4. Carreno V, Porres JC, Mora I, et al. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon. Liver 1987;7:325-32.
5. Valentine TE, Steinmann J, Arnold W. Detection of hepatitis B virus DNA in serum with nucleic acid probes labeled with 32P, biotin, alkaline phosphatase or sulphone. Mol Cell Probes 1991;5:299-305.
6. Quiroga JA, Bartolome J, Porres JC, et al. Identification of different degrees of hepatitis B virus (HBV) replication by serological (HBV-DNAp, HBcAg and HBV-DNA) and histological (HBcAg) methods. Liver 1987;7:169-75.
7. Kaneko S, Feinstone SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using polymerase chain reaction technique. J Clin Microbiol 1989;27:1930-3.
8. Barlet V, Zarski JP, Thelu MA, et al. Advantage of PCR for detecting low amounts of HBV DNA in patients' sera. Res Virol 1991;142: 373-9.
9. Shindo M, Di Bisceglie AM, Cheung L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700-4.
10. Niitsuma H, Ishii M, Saito Y, et al. Prevalence of precore-defective mutant hepatitis B virus in HBV carriers. J Med Virol 1995;46:397-402.
11. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155: 335-50.
12. Ehata T, Omata M, Yokosuka O, et al. Amino acid residues of core region of hepatitis B virus: Asymptomatic carriers versus patients with liver disease. J Gastroenterol Hepatol 1991;6:292-6.
13. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994;68:8102-10.
14. Carloni G, Colloca S, Delfini CTI, et al. Detection of HBV infectivity by spot hybridization in HBeAg-negative chronic carriers: HBV DNA in sera from asymptomatic and symptomatic subjects. J Med Virol 1987;21:15-23.
15. Chen DS. Natural history of chronic hepatitis B virus infection: New light on an old story. J Gastroenterol Hepatol 1993;8:470-5.
16. Bertoletti A, Costanzo A, Chisari FV, et al. Cytotoxic T-lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994;180:933-43.
17. Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Eng J Med 1991;324:1699-704.
18. Yoshiba M, Sekiyama K, Sugata F, et al. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992;37:1253-9.
19. Ogata N, Miller RH, Ishak KG, et al. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993;194:263-76.
20. Tong SP, Li JS, Vitvitski L, et al. Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: Relevance of pregenome encapsidation signal. Virology 1992;191:237-45.